Head to Head Survey: Spectral AI (NASDAQ:MDAI) and Titan Medical (NASDAQ:TMDIF)

Spectral AI (NASDAQ:MDAI) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for Spectral AI and Titan Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	0	0	3	1	3.25
Titan Medical	0	0	0	0	N/A

Spectral AI presently has a consensus target price of $4.50, suggesting a potential upside of 206.12%. Given Spectral AI’s higher probable upside, analysts plainly believe Spectral AI is more favorable than Titan Medical.

Institutional & Insider Ownership

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 56.7% of Spectral AI shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Spectral AI and Titan Medical’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$22.53 million	1.14	-$20.85 million	N/A	N/A
Titan Medical	$17.63 million	0.27	$6.95 million	$0.05	0.82

Titan Medical has lower revenue, but higher earnings than Spectral AI.

Profitability

This table compares Spectral AI and Titan Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spectral AI	-89.85%	N/A	-104.64%
Titan Medical	N/A	-71.86%	-45.19%

Volatility and Risk

Spectral AI has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500.

Summary

Spectral AI beats Titan Medical on 8 of the 12 factors compared between the two stocks.

About Spectral AI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.